Subjects with dry eye symptoms
Conditions
Interventions
multisupplement(3 months)
placebo(3 months)
Sponsors
Tsubota-lab
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: people who have dry eye symptom
Exclusion criteria
Exclusion criteria: People with active eye diseases except dry eye disease Patients who take any supplements. Patients with serious systemic diseases People whom the investigator or the subinvestigators consider to be ineligible for the intervention therapy in any other reason pregnant woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dry eye parameter(Tear film break-up time(BUT),Strip meniscometry,Schirmer1 test,Symptoms(DEQS,VAS)) | — |
Secondary
| Measure | Time frame |
|---|---|
| The grading of corneal and conjunctival staining,meibomian gland evaluation,8-OHdG in blood,HEL in blood | — |
Countries
Japan
Contacts
Public ContactShintaro Yamada
Tsubota-lab Director
Outcome results
None listed